John Q. Trojanowski

Physiology · 2000–2023

A researcher in the Science corpus: 68 papers; trusts 10 researchers and is trusted by 41 researchers here, as inferred from the citation graph.

Subfields

• Physiology — 426 citations into it; #113 of 2,276 by trust here, #11 by citations
• Neurology — 419 citations into it; #75 of 1,455 by trust here, #2 by citations
• Psychiatry and Mental health — 279 citations into it; #81 of 1,338 by trust here, #7 by citations
• Molecular Biology — 254 citations into it
• Cellular and Molecular Neuroscience — 164 citations into it; #1,944 of 2,998 by trust here, #75 by citations
• Cognitive Neuroscience — 107 citations into it; #3,806 of 10,852 by trust here, #1,864 by citations
• Artificial Intelligence — 7 citations into it

Whom John Q. Trojanowski trusts overall

Their strongest outbound trust, strongest first, inferred from their citations.

1. H. Braak
2. Kelvin C. Luk
3. Clifford R. Jack Jr.
4. Yuhai Wu
5. V. Lee

Who trusts John Q. Trojanowski overall

1. Heung-Il Suk
2. Nicole Exner
3. Leonidas Stefanis
4. Michael T. Heneka
5. L. Volpicelli-Daley
6. Kelvin C. Luk
7. D. Selkoe
8. Daoqiang Zhang
9. L. Ittner
10. Jing L Guo

Papers from John Q. Trojanowski's perspective

Ordered by how strongly the researchers John Q. Trojanowski trusts endorse each paper. Same corpus, a different order for every researcher.

1. Ubiquitinated TDP-43 in Frontotemporal Lobar Degeneration and Amyotrophic Lateral Sclerosis (Science)
2. Stages of the Pathologic Process in Alzheimer Disease: Age Categories From 1 to 100 Years (Journal of Neuropathology and Experimental Neurology)
3. S3‐03‐05: Transmission and Spreading of Tauopathy in Transgenic Mouse Brain
4. Oligomeric amyloid β associates with postsynaptic densities and correlates with excitatory synapse loss near senile plaques (Proceedings of the National Academy of Sciences of the United States of America)
5. Classification and basic pathology of Alzheimer disease (Acta Neuropathologica)
6. Trans-Synaptic Spread of Tau Pathology In Vivo (PLoS ONE)
7. Neuropathology of Cognitively Normal Elderly (Journal of Neuropathology and Experimental Neurology)
8. Role of genes and environments for explaining Alzheimer disease. (Archives of General Psychiatry)
9. Neuropathologically defined subtypes of Alzheimer's disease with distinct clinical characteristics: A retrospective study (Lancet Neurology)
10. Age, neuropathology, and dementia. (New England Journal of Medicine)

Their papers

• Ataxin-2 intermediate-length polyglutamine expansions are associated with increased risk for ALS (2010) — 1,315 citations
• Chaperone Suppression of α-Synuclein Toxicity in a Drosophila Model for Parkinson's Disease (2001) — 1,153 citations
• Common variants in MS4A4/MS4A6E, CD2uAP, CD33, and EPHA1 are associated with late-onset Alzheimer’s disease (2011) — 1,887 citations
• Neurodegenerative diseases: a decade of discoveries paves the way for therapeutic breakthroughs (2004) — 724 citations
• Clinical and pathological diagnosis of frontotemporal dementia: report of the Work Group on Frontotemporal Dementia and Pick's Disease. (2001) — 1,460 citations
• Cerebrospinal Fluid Biomarker Signature in Alzheimer’s Disease Neuroimaging Initiative Subjects (2009) — 2,163 citations
• Spreading of pathology in neurodegenerative diseases: a focus on human studies (2015) — 748 citations
• The acetylation of tau inhibits its function and promotes pathological tau aggregation (2011) — 684 citations
• Demonstrated brain insulin resistance in Alzheimer's disease patients is associated with IGF-1 resistance, IRS-1 dysregulation, and cognitive decline. (2012) — 1,731 citations
• A harmonized classification system for FTLD-TDP pathology (2011) — 941 citations
• Genetic meta-analysis of diagnosed Alzheimer’s disease identifies new risk loci and implicates Aβ, tau, immunity and lipid processing (2019) — 2,422 citations
• Inflammation and white matter degeneration persist for years after a single traumatic brain injury. (2013) — 980 citations
• Identifying Neuroimaging and Proteomic Biomarkers for MCI and AD via the Elastic Net (2011) — 60 citations
• Multi-ancestry genome-wide meta-analysis of 56,241 individuals identifies LRRC4C, LHX5-AS1 and nominates ancestry-specific loci PTPRK, GRB14, and KIAA0825 as novel risk loci for Alzheimer disease: the Alzheimer Disease Genetics Consortium (2023) — 1,168 citations
• Large-scale proteomic analysis of Alzheimer’s disease brain and cerebrospinal fluid reveals early changes in energy metabolism associated with microglia and astrocyte activation (2020) — 868 citations
• Limbic-predominant age-related TDP-43 encephalopathy (LATE): consensus working group report (2019) — 1,263 citations
• CSF biomarkers of Alzheimer’s disease concord with amyloid-β PETand predict clinical progression: A study of fully automated immunoassays in BioFINDER and ADNI cohorts (2018) — 715 citations
• Neurodegenerative disease concomitant proteinopathies are prevalent, age-related and APOE4-associated (2018) — 627 citations
• Altered Bile Acid Profile Associates with Cognitive Impairment in Alzheimer’s Disease – An Emerging Role for Gut Microbiome (2018) — 597 citations
• The Parkinson's progression markers initiative (PPMI) – establishing a PD biomarker cohort (2018) — 595 citations